Clinical Trial Update: Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating inhaled nitric oxide (INO) for prevention of Bronchopulmonary Dysplasia in preterm infants has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Inhaled Nitric Oxide (INO) (nitric oxide)

Snippet

Sponsor: Mallinckrodt | Conditions: Bronchopulmonary Dysplasia | Phase 3 | Status: COMPLETED | Results posted: 2015-08-11